Top 20 Commercial Due Diligence (CDD) Advisory 2024

This report forms part of the Ranking News Advisory series, which evaluates specialized advisory firms across global strategy, transaction, and corporate advisory markets.

Commercial Due Diligence (CDD) advisory firms play a critical role in transaction processes by evaluating the commercial viability of investment opportunities. Their work focuses on assessing market dynamics, growth potential, competitive positioning, customer behavior, and revenue sustainability, providing investors with forward-looking insight into whether a target business can deliver its projected performance.

Unlike financial due diligence, which validates historical financial information, commercial due diligence is inherently forward-looking and closely tied to investment thesis development. As a result, CDD providers are deeply embedded within private equity deal processes, often operating under tight timelines and directly influencing investment decisions.

The market is characterized by a mix of specialized strategy boutiques and sector-focused advisory firms, many of which maintain strong relationships with private equity sponsors. These firms differentiate themselves through analytical rigor, speed of execution, and deep industry expertise.

This ranking identifies firms that demonstrate consistent engagement in commercial due diligence and transaction-related strategy advisory across global markets.

Market Overview

The commercial due diligence market has expanded significantly alongside the growth of private equity activity. As competition for assets has intensified, investors have placed greater emphasis on validating market assumptions, understanding demand drivers, and identifying downside risks prior to acquisition.

CDD providers typically operate at the intersection of strategy consulting and transaction advisory. Their role is to translate complex market data into clear investment recommendations within compressed timelines. This requires both analytical capability and sector familiarity.

Mid-market private equity transactions represent a significant portion of demand, where investors seek advisors capable of delivering focused and actionable insights. In this segment, boutique firms often compete effectively against larger consulting platforms by offering greater flexibility and senior-level involvement.

Sector specialization has become increasingly important. Firms with deep expertise in areas such as healthcare, technology, consumer, and industrial markets are better positioned to deliver high-quality analysis and secure repeat engagements.

Industry Trend — 2024

In 2024, commercial due diligence continues to evolve toward greater analytical depth and sector specialization. Private equity firms are increasingly demanding more granular insights into customer segmentation, pricing power, and competitive positioning.

Data availability has significantly expanded, allowing CDD providers to incorporate alternative data sources, customer-level analysis, and real-time market indicators into their assessments. This has improved the precision of market sizing and growth projections.

Another key trend is the integration of CDD with post-deal value creation planning. Investors are no longer satisfied with standalone diligence reports—they expect actionable recommendations that can be implemented immediately following acquisition.

Sector specialization is also becoming more pronounced. Firms with deep expertise in healthcare, software, industrials, and consumer sectors are better positioned to secure repeat mandates from private equity sponsors.

Speed remains a defining characteristic of the category. Firms that can deliver high-quality insights within tight timelines continue to dominate competitive deal environments.

Methodology — Core Eligibility Criteria

To ensure structural consistency within the category, firms were evaluated based on the following criteria:

• Provides commercial due diligence services for transactions
• Demonstrates strong private equity engagement
• Focuses on market, growth, and competitive analysis
• Maintains dedicated transaction or diligence teams
• Exhibits sector specialization and analytical rigor

Large multi-service consulting platforms without a clear CDD-focused positioning were excluded.

Methodology — Ranking Factors

Firms included in the ranking were evaluated using a combination of qualitative and structural considerations. Key factors include:

• Depth of commercial analysis and market insight
• Strength of private equity relationships
• Ability to deliver clear investment recommendations
• Speed and reliability under transaction timelines
• Sector expertise and domain specialization
• Quality of data and analytical frameworks
• Institutional reputation in deal environments

The objective of the ranking is to identify firms whose advisory platforms maintain sustained relevance within the global corporate governance ecosystem.

The ranking universe consisted of approximately 55 Commercial Due Diligence (CDD) Advisory Firms, from which 20 institutions were selected for inclusion.

Tier classifications reflect relative institutional positioning and do not represent performance rankings or recommendations.

---

Tier I — Leading CDD Advisory Firms

LEK Consulting

• Headquarters: London, United Kingdom
• Founded: 1983

LEK Consulting is one of the most established commercial due diligence providers globally, with a strong presence across private equity and corporate transaction advisory. The firm has built its reputation on delivering rigorous, data-driven analysis under compressed deal timelines, making it a frequent participant in high-stakes investment processes.

Its commercial due diligence work focuses on market sizing, growth forecasting, competitive positioning, and customer segmentation. LEK’s sector expertise spans healthcare, life sciences, consumer, and industrials, enabling the firm to provide highly tailored insights aligned with specific industry dynamics.

The firm maintains long-standing relationships with private equity sponsors, contributing to consistent deal flow and repeat engagements. Its ability to translate complex market data into clear investment recommendations has reinforced its role as a trusted advisor in transaction environments.

LEK’s combination of analytical rigor, sector depth, and execution reliability positions it as a leading firm within the global commercial due diligence landscape.

OC&C Strategy Consultants

• Headquarters: London, United Kingdom
• Founded: 1987

OC&C Strategy Consultants is a strategy boutique with a strong focus on commercial due diligence and growth strategy. The firm is particularly recognized for its work in consumer, retail, media, and technology sectors, where it provides detailed insights into demand drivers and competitive dynamics.

Its approach to commercial due diligence emphasizes customer behavior analysis, pricing structures, and market segmentation. This allows clients to evaluate revenue sustainability and growth potential with a high degree of confidence.

OC&C operates with a focused sector model and senior-led engagement structure, ensuring consistency in analytical quality and strategic clarity. Its deep expertise in selected industries enables the firm to deliver highly relevant and actionable insights.

The firm’s strong positioning within private equity ecosystems supports its continued role as a leading advisor in commercial due diligence engagements.

Altman Solon

• Headquarters: Boston, United States
• Founded: 2020

Altman Solon is a specialized strategy consulting firm focused on telecommunications, media, and technology sectors. The firm has established a strong presence in commercial due diligence, particularly in transactions involving digital infrastructure, software, and data-driven business models.

Its advisory work combines detailed market analysis with deep sector knowledge, enabling clients to assess growth potential and competitive positioning in rapidly evolving industries. The firm frequently supports private equity investors evaluating complex technology assets.

Altman Solon’s sector specialization allows it to provide granular insights into industry dynamics, including pricing trends, customer behavior, and market structure. Its focused approach has contributed to strong relationships within the private equity community.

The firm’s ability to deliver targeted, high-quality analysis positions it as a leading CDD advisor within its core sectors.

Simon-Kucher & Partners

• Headquarters: Bonn, Germany
• Founded: 1985

Simon-Kucher & Partners is a global strategy consulting firm specializing in pricing and revenue strategy, with a strong role in commercial due diligence engagements. The firm is frequently engaged to assess pricing power, revenue sustainability, and monetization strategies within transaction contexts.

Its expertise in pricing analytics and market segmentation provides a differentiated perspective in commercial due diligence, particularly in industries where pricing dynamics are central to value creation. The firm operates across sectors including healthcare, technology, and consumer goods.

Simon-Kucher’s analytical approach combines quantitative modeling with industry insight, enabling clients to make informed investment decisions. Its work often complements broader market assessments by providing detailed analysis of revenue drivers.

This specialized capability positions the firm as a leading advisor in commercially focused diligence work.

ClearView Healthcare Partners

• Headquarters: Boston, United States
• Founded: 2007

ClearView Healthcare Partners is a strategy consulting firm specializing in life sciences and healthcare commercial due diligence. The firm provides advisory services across pharmaceuticals, biotechnology, and medical devices, supporting both corporate clients and private equity investors.

Its work focuses on market opportunity assessment, product positioning, and competitive analysis within highly regulated and complex healthcare markets. ClearView’s deep domain expertise enables it to deliver detailed and reliable insights in specialized segments.

The firm’s strong presence in healthcare transactions and its data-driven analytical approach have contributed to consistent engagement with private equity clients. Its ability to navigate regulatory complexity and evolving market conditions enhances its relevance in diligence processes.

ClearView’s sector focus and analytical rigor position it as a leading CDD advisor within the healthcare domain.

---

Tier II — Established CDD Advisory Firms

(Alphabetical order)

Back Bay Life Science Advisors

• Headquarters: Boston, United States
• Founded: 2007

Back Bay Life Science Advisors is a specialized consulting firm focused on commercial due diligence and strategic advisory within the biopharmaceutical and healthcare sectors. The firm works closely with private equity investors, pharmaceutical companies, and growth-stage healthcare businesses to evaluate market opportunities and investment risks.

Its commercial due diligence engagements typically involve detailed analysis of therapeutic markets, competitive landscapes, and product positioning. Back Bay’s ability to combine scientific understanding with commercial insight allows clients to assess both market viability and execution feasibility in complex healthcare environments.

The firm is particularly active in supporting investment decisions involving emerging therapies, niche indications, and evolving treatment paradigms. Its strong domain expertise and focused advisory model position it as a credible participant in healthcare-focused transaction advisory.

Clarion Healthcare

• Headquarters: Boston, United States
• Founded: 2008

Clarion Healthcare is a strategy consulting firm specializing in life sciences and healthcare commercial due diligence. The firm provides advisory services to private equity investors and corporate clients, focusing on market opportunity assessment, competitive positioning, and growth potential.

Its work often involves evaluating therapeutic areas, treatment adoption trends, and market access considerations within highly specialized healthcare segments. Clarion’s deep domain expertise enables it to deliver targeted insights that support investment decision-making in complex and regulated markets.

The firm’s engagement model emphasizes analytical rigor and close client collaboration, allowing it to operate effectively within transaction timelines. Its consistent involvement in healthcare-focused diligence engagements supports its position within the commercial due diligence landscape.

CRA (Charles River Associates)

• Headquarters: Boston, United States
• Founded: 1965

Charles River Associates (CRA) is an economic and consulting firm with capabilities extending into commercial due diligence, particularly in situations requiring rigorous quantitative analysis. The firm supports corporate clients and investors by evaluating market dynamics, competitive behavior, and regulatory factors.

Its commercial due diligence work often involves detailed modeling, demand analysis, and competitive assessment, particularly in industries where economic factors and regulatory considerations play a central role. CRA’s analytical depth enables it to provide structured and defensible insights in complex transaction environments.

The firm operates across sectors including healthcare, energy, and financial services, often supporting high-stakes investment decisions. Its integration of economic expertise and transaction advisory supports its role as a differentiated participant in commercial due diligence.

DeciBio Consulting

• Headquarters: Los Angeles, United States
• Founded: 2009

DeciBio Consulting is a specialized consulting firm focused on precision medicine, diagnostics, and life sciences markets. The firm provides commercial due diligence and market analysis services to private equity investors and corporate clients evaluating complex healthcare opportunities.

Its work typically involves assessing market size, growth drivers, competitive positioning, and technology adoption trends within highly specialized segments. DeciBio’s scientific expertise allows it to translate technical innovation into commercially relevant insights.

The firm is frequently engaged in transactions involving emerging diagnostics, genomics, and advanced therapeutics. Its focused positioning and analytical rigor support its role as a reliable advisor in niche healthcare diligence engagements.

Edgeworth Economics

• Headquarters: Washington, D.C., United States
• Founded: 2009

Edgeworth Economics is a consulting firm specializing in economic analysis and data-driven advisory, with selective involvement in commercial due diligence. The firm supports clients in evaluating market dynamics, competitive structure, and pricing behavior through rigorous quantitative methods.

Its work often focuses on industries where economic modeling and statistical analysis are critical to understanding market conditions. In transaction contexts, Edgeworth provides structured analysis that supports investment decisions and strategic positioning.

The firm’s analytical approach is particularly relevant in complex markets with regulatory or competitive constraints. Its ability to deliver data-driven insights positions it as a specialized participant in commercial due diligence.

Health Advances

• Headquarters: Boston, United States
• Founded: 1992

Health Advances is a strategy consulting firm focused on the healthcare and life sciences sectors, with a strong presence in commercial due diligence. The firm provides market assessments, competitive analysis, and growth strategy advisory to corporate clients and private equity investors.

Its work often involves evaluating therapeutic markets, product pipelines, and commercialization strategies, particularly in complex healthcare environments. Health Advances combines deep domain expertise with structured analytical frameworks to deliver actionable insights.

The firm’s long-standing presence in healthcare advisory and consistent involvement in transaction-related engagements support its credibility within the commercial due diligence market.

Keystone Strategy

• Headquarters: Boston, United States
• Founded: 2003

Keystone Strategy operates at the intersection of economics, data science, and strategy, with a growing role in commercial due diligence engagements. The firm provides analytical advisory services that focus on market dynamics, pricing strategy, and competitive positioning.

Its work often involves complex modeling and data analysis, enabling clients to assess growth potential and investment risk with greater precision. Keystone’s integration of quantitative methods differentiates it within the commercial due diligence landscape.

The firm supports both corporate clients and investors, particularly in technology and data-intensive industries.

Putnam Associates

• Headquarters: Boston, United States
• Founded: 1988

Putnam Associates is a strategy consulting firm specializing in pharmaceutical and life sciences markets, with a strong focus on commercial due diligence. The firm provides analysis of market opportunity, product positioning, and competitive dynamics.

Its work supports investment decisions involving complex healthcare assets, where regulatory considerations and market structure play a critical role. Putnam’s deep industry expertise enables it to deliver highly relevant insights for transaction advisory.

The firm maintains strong relationships with both corporate and private equity clients, supporting its consistent engagement in healthcare-focused diligence work.

Solon Management Consulting

• Headquarters: Munich, Germany
• Founded: 2001

Solon Management Consulting is a strategy consulting boutique specializing in telecommunications, media, and technology sectors. The firm provides commercial due diligence and growth strategy advisory to corporate clients and private equity investors.

Its work focuses on evaluating market dynamics, competitive positioning, and revenue potential within rapidly evolving digital industries. Solon’s sector expertise allows it to deliver detailed insights into complex and technology-driven markets.

The firm’s consistent involvement in TMT transactions supports its position as a strong participant in commercial due diligence advisory.

Trinity Life Sciences

• Headquarters: Waltham, United States
• Founded: 1996

Trinity Life Sciences is a consulting firm focused on pharmaceutical and biotechnology markets, with strong capabilities in commercial due diligence. The firm provides advisory services across market assessment, product strategy, and competitive analysis.

Its work supports both corporate strategy and transaction-related decision-making, particularly in complex healthcare markets. Trinity’s integration of data analytics and domain expertise enables it to deliver structured and actionable insights.

The firm’s strong presence in life sciences advisory supports its continued relevance in commercial due diligence engagements.

---

Tier III — Specialist CDD Advisory Firms

(Alphabetical order)

• Innosight
• MarketBridge
• Prophet
• Sia Partners
• West Monroe

---

Remarks

Commercial due diligence remains a central component of transaction decision-making, providing forward-looking insight into market dynamics, competitive positioning, and growth sustainability. As private equity and corporate investors continue to operate in increasingly competitive deal environments, the role of CDD advisors has become more critical in validating investment theses under compressed timelines.

Firms in this category are differentiated not only by analytical rigor but also by their ability to deliver clear, actionable insights that directly influence investment outcomes. Sector specialization, data-driven methodologies, and strong sponsor relationships continue to define leading positions within the market.

The composition of this ranking reflects a deliberate focus on advisory firms with established engagement in transaction-driven commercial analysis, distinct from broader strategy consulting or financial diligence services. This separation is intended to preserve clarity within the advisory taxonomy and ensure consistency across ranking categories.

Tier classification reflects relative institutional positioning within the commercial due diligence advisory segment and does not represent performance rankings or investment recommendations.

---

Organizations included in this ranking may request information regarding authorized use of the Ranking News designation for marketing and communications purposes.

Recognition

Organizations included in the Top 20 Commercial Due Diligence (CDD) Advisory 2024 ranking may request information regarding authorized use of the Ranking News designation badge for marketing and communications purposes.

Recognized institutions may reference the designation in:

• corporate websites
• investor communications
• marketing materials
• client presentations

Licensing inquiries:
[email protected]